Diagnosis

Deep venous thrombosis

Clot formation originating in the deep venous system.

Also known as: DVT, Venous thromboembolism

Etiology

Cause - Virchows triad [ycs]

  1. Stasis: Immobility, venous pressure/mechanical compression: neoplasm, pregnancy, stenosis

  2. Hypercoagulable blood:

    • Genetic deficiencies: Anticoagulation proteins C and S, antithrombin III deficiency, factor V Leiden mutation, Polycythaemia rubra vera

    • Acquired: Cancer, sepsis, myocardial infarction, heart failure, vasculitis, systemic lupus erythematosus and lupus anticoagulant, inflammatory bowel disease, nephrotic syndrome, burns, oral estrogens, smoking, hypertension, diabetes, dehydration

  3. Vessel injury: Trauma, surgery, venous catheters, previous DVT, IV drug abuse

Pathophysiology [ycs]

  1. Virchow triad --> cytokine production --> leukocyte adhesion to the endothelium --> promoting venous thrombosis

  2. Thrombosis is a protective mechanism that prevents the loss of blood

  3. Fibrinolysis counteracts thrombosis

  4. Obstruction of the venous reflux --> erythema, swelling, cyanosis, pain, fever, prominent superficial veins, pain with passive dorsiflexion of the foot (Homan’s sign), venous gangrene, Phlegmasia cerulea dolens (massive swelling, cyanosis, and pain)

  5. Remodeling process --> Fibrosis

Anatomic distribution [ycs]

Risk factors allowing thrombosis to occur - Virchows triad [ycs]

Complications [ycs]

Epidemiology

Incidence per 100.000 [1q2][vuf][ssg][acp]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Edema, Homan's sign

Clinical findings

Elevated D-dimer, Elevated Sedimentation Rate

Anamneses

Surgery, Trauma

Localized findings

Pain
Radiates
Lower bodyArm
Onset
Subacute (hours)
Pattern
Constant
Provoked by
Activity
Quality
CrampingDullPressing
Severity
Mild (1-3)Moderate (4-7)
Pain
Radiates
Retrosternal
Onset
Acute (minutes)Subacute (hours)
Pattern
Constant
Provoked by
Respiration
Severity
Mild (1-3)Moderate (4-7)
Rash
Radiates
ArmLower body
Distribution
Asymmetric
Lesion type
Erythema
Color
Red
Associated symptom
PainSwelling
Palpation
BlanchingPainWarmth
Swelling
Radiates
ArmLower body
Onset
Subacute (hours)
Pattern
Constant

Approach

Wells clinical prediction guide

Pretest probability of deep venous thrombosis: high-risk <0p (5%), moderate-risk 1-2p (17%), or low-risk >3p (53%):

Treatment

  1. Anticoagulation: first episode --> 3-6 months. Recurrent episodes --> >1 year [2z7]

    • 1st line --> direct oral anticoagulants: dabigatran, rivaroxaban, apixaban

    • 2nd line --> vitamin K antagonist (Warfarin)

    • 3rd line --> Low molecular weight heparin (LMWH)

  2. Endovascular mechanical thrombolysis: immediate passage to prevent pulmonary embolism and postthrombotic syndrome

    • Indication:

      • Iliofemoral or IVC thrombosis --> phlegmasia

      • Anticoagulation is contraindicated (intracranial bleeding, recent major surgery (brain/eye/spinal cord), pregnancy, malignant hypertension, severe thrombocytopenia)

      • Pulmonary embolism and systemic shock

      • Inferior vena cava filter is not recommended in patients on anticoagulant therapy

    • Catheter-directed thrombolysis

    • Mechanical thrombectomy

    • Angioplasty

    • Stenting of venous obstructions

  3. Surgery:

    • Surgical Thrombectomy: phlegmasia cerulea dolens (massive swelling)

    • Valvuloplasty of chronic venous insufficiency

Differential diagnoses

Acute extremity ischemia, Arthritis, Bakers cyst, Cellulitis, Chronic venous insufficiency, Erysipelas, Heart failure, Lymphedema, Muscle tear, Necrotizing fasciitis, Nephrotic syndrome, Peripheral neuropathy, Postphlebitic syndrome, Pulmonary embolism, Superficial venous thrombosis, Thrombophlebitis, Varices


References

[1] Waheed SM, Kudaravalli P, Hotwagner DT. Deep Venous Thrombosis. [Updated 2023 Jan 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507708/

[2] Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009 Nov;28(4):401-9.

[3] Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003 Jan;25(1):1-5.

[4] Arshad N, Isaksen T, Hansen JB, Brækkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol. 2017 Apr;32(4):299-305.

[5] Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):3-14.

[6] http://emedicine.medscape.com/article/1911303 (2014-01-02); [Medscape]

[7] White RH. The epidemiology of venous thromboembolism. Circulation. 2003 Jun 17;107(23 Suppl 1):I4-8.

Scroll to top